BIOMAT Database Logo BIOMAT Database Logo

Reduced RNA polymerase II transcription in extracts of cockayne syndrome and xeroderma pigmentosum/Cockayne syndrome cells. 1997

G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
Laboratory of Molecular Pathology, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.

The hereditary disease Cockayne syndrome (CS) is a complex clinical syndrome characterized by arrested post-natal growth as well as neurological and other defects. The CSA and CSB genes are implicated in this disease. The clinical features of CS can also accompany the excision repair-defective hereditary disorder xeroderma pigmentosum (XP) from genetic complementation groups B, D or G. The XPB and XPD proteins are subunits of RNA polymerase II (RNAP II) transcription factor IIH (TFIIH). We show here that extracts of CS-A and CS-B cells, as well as those from XP-B/CS cells, support reduced levels of RNAP II transcription in vitro and that this feature is dependent on the state or quality of the template.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003057 Cockayne Syndrome A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I (classical; CSA) is early childhood onset in the second year of life; type II (congenital; CSB) is early onset at birth with severe symptoms; type III (xeroderma pigmentosum; XP) is late childhood onset with mild symptoms. Progeria-Like Syndrome,Cockayne Syndrome Type 3,Cockayne Syndrome Type C,Cockayne Syndrome, Group A,Cockayne Syndrome, Group B,Cockayne Syndrome, Group C,Cockayne Syndrome, Type A,Cockayne Syndrome, Type B,Cockayne Syndrome, Type C,Cockayne Syndrome, Type I,Cockayne Syndrome, Type II,Cockayne Syndrome, Type III,Dwarfism-Retinal Atrophy-Deafness Syndrome,Group A Cockayne Syndrome,Group B Cockayne Syndrome,Group C Cockayne Syndrome,Progeroid Nanism,Type A Cockayne Syndrome,Type B Cockayne Syndrome,Type C Cockayne Syndrome,Type I Cockayne Syndrome,Type II Cockayne Syndrome,Type III Cockayne Syndrome,Progeria Like Syndrome,Progeria-Like Syndromes,Syndrome, Cockayne,Syndrome, Progeria-Like
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012319 RNA Polymerase II A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6. DNA-Dependent RNA Polymerase II,RNA Pol II,RNA Polymerase B,DNA Dependent RNA Polymerase II
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D014983 Xeroderma Pigmentosum A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA. Kaposi Disease,Kaposi's Disease,Kaposis Disease

Related Publications

G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
Reduced RNA polymerase II transcription in intact and permeabilized Cockayne syndrome group B cells.
April 1997, Proceedings of the National Academy of Sciences of the United States of America,
G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
Xeroderma pigmentosum and Cockayne syndrome.
April 1978, Pediatrics,
G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
Cockayne syndrome and xeroderma pigmentosum.
November 2000, Neurology,
G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
Xeroderma pigmentosum-Cockayne syndrome complex.
November 2020, The Indian journal of medical research,
G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
Xeroderma pigmentosum-Cockayne syndrome complex.
April 2017, Orphanet journal of rare diseases,
G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
Transcription-associated breaks in xeroderma pigmentosum group D cells from patients with combined features of xeroderma pigmentosum and Cockayne syndrome.
September 2005, Molecular and cellular biology,
G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
Prenatal diagnosis of xeroderma pigmentosum and Cockayne syndrome.
October 1994, Prenatal diagnosis,
G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
Competent transcription initiation by RNA polymerase II in cell-free extracts from xeroderma pigmentosum groups B and D in an optimized RNA transcription assay.
November 1997, Biochimica et biophysica acta,
G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
Rare case of Cockayne syndrome with xeroderma pigmentosum.
May 2000, Acta dermato-venereologica,
G L Dianov, and J F Houle, and N Iyer, and V A Bohr, and E C Friedberg
RNA dependent DNA polymerase in cells of xeroderma pigmentosum.
July 1971, Biochemical and biophysical research communications,
Copied contents to your clipboard!